Advertisement
Donate
|
Join/Renew
|
Store
|
View Cart
|
Log In
Search SNMMI.org
Search SNMMI Learning Center
Value Initiative
|
Physicians
|
Technologists
|
Scientists
|
Residents
|
Healthcare Provider
|
Patients
NEWS & PUBLICATIONS
News
Newsletters
Journals
Books
MEMBERSHIP
Join/Renew
Benefits
Categories
Download a Member Application
CONNECT
Membership Directory
Chapters
Centers of Excellence
Councils
Member Spotlight
Women in Nuclear Medicine
Grants, Awards and Scholarships
SNMMI Fellow
EDUCATION
2020 Call for Abstracts
MEETINGS & EVENTS
Calendar of Events
Webinars
2020 Mid-Winter Meeting
2020 Annual Meeting
Targeted Radionuclide Therapy Conference
Nuclear Medicine & Molecular Imaging Week
2019 Virtual Meeting
PET/MRI Workshop
2019 Therapeutics Conference
SNMMI-TS Leadership Academy
SNMMI Future Leaders Academy
ADVOCACY
Coding & Reimbursement
Government Relations News
Radiopharmaceutical Supply News
USP 825
Technologist State Issues
Position Statements
Coalition for PET Drugs
EVIDENCE & QUALITY
Clinical Guidelines
Quality
Practice Resources
Dose Optimization
About Quality & Practice
RESEARCH
Clinical Trials Network
Preclinical Imaging
Nuclear Medicine Clinical Trial Group, LLC
Research: Learn More
ABOUT SNMMI
Strategic Plan
Bylaws & Procedures
Governance - SNMMI
Governance - SNMMI-TS
History
Grants, Awards, and Scholarships
Annual Reports
Career Center
About Nuclear Medicine & Molecular Imaging
International Collaboration
Outreach
Support SNMMI
Contact Us
HOME
>
ADVOCACY
>
Position Statements
In This Section
Coding & Reimbursement
For Hospitals (APCs, IPPS)
For Private Practices (RBRVS)
Coding Q&As
Coding News
Government Relations News
Radiopharmaceutical Supply News
USP 825
Technologist State Issues
State TAG Team
How to be a Grassroots Advocate
Position Statements
Coalition for PET Drugs
Advertisement
Position Statements
ASNC-SNMMI Joint Position Statment on the Clinical Indications for Myocardial Perfusion PET
Radiopharmaceutical Reimbursement Policy Statement
Dose Optimization Policy Statement
FDA Radiation Reduction Program Policy Statement
Use of Compounded Radiopharmaceuticals and Adjunct Drug Preparations Policy Statement
Joint Statement on Radioactive Precautions Following Radioactive Iodine Therapy Policy Statement
Beyond-Use Dates (BUD) for Tc-99m Policy Statement
Domestic Isotope Availability Policy Statement
Conditions of Participation/Direct Supervision Policy Statement
Nuclear Medicine Research Funding Policy Statement
RELATED CONTENT
Radiopharmaceutical Supply News
Committee on Outreach
SNMMI Hospital Administrators Survey Result Highlights
Councils
JNM Articles on Dose Optimization